The present disclosure is related in general to medical devices operable to access bone marrow and specifically to apparatus and methods for penetrating a bone and associated bone marrow with a powered driver and inserting an intraosseous device into the bone marrow.
Every year, millions of patients are treated for life-threatening emergencies in the United States. Such emergencies include shock, trauma, cardiac arrest, drug overdoses, diabetic ketoacidosis, arrhythmias, burns, and status epilepticus just to name a few. For example, according to the American Heart Association, more than 1,500,000 patients suffer from heart attacks (myocardial infarctions) every year, with over 500,000 of them dying from its devastating complications.
Obtaining satisfactorily vascular access may be a critical problem in approximately five (5%) percent to ten (10%) percent of patients treated in either prehospital or hospital settings. In the U.S. approximately six million patients annually may experience problems with traditional intravenous access. An essential element for treating medical emergencies is rapid establishment of vascular access to administer drugs and fluids directly into the circulatory system. Whether in an ambulance by paramedics, or in an emergency room by emergency specialists, the goal is the same—administer life-saving drugs and fluids. To a large degree, the ability to successfully treat such critical emergencies is dependent on skill and luck of an operator in accomplishing vascular access.
While it is relatively easy to start an IV on many patients, doctors, nurses and paramedics often experience great difficulty establishing IV access in some patients. These patients are probed repeatedly with sharp needles in an attempt to solve this problem and may require an invasive procedure to finally establish an intravenous route. A further complicating factor in achieving IV access occurs “in the field” (e.g., at the scene of an accident or during ambulance transport) where it is difficult to see the target and/or excessive motion makes accessing the venous system very difficult.
In the case of some patients (e.g., those with chronic disease or the elderly), the availability of easily-accessible veins may be depleted. Other patients may have no available IV sites due to anatomical scarcity of peripheral veins, obesity, extreme dehydration, and/or previous IV drug use. For these patients, finding a suitable site for administering lifesaving drugs becomes a monumental and frustrating task. While morbidity and mortality statistics are not generally available, it is known that many patients with life-threatening emergencies have died of ensuing complications because access to the vascular system with life-saving IV therapy was delayed or simply not possible. For such patients, an alternative approach is required.
Powered drivers associated with intraosseous (IO) devices typically include a housing with various types of motors and/or gear assemblies disposed therein. A rotatable shaft may be disposed within the housing and connected with a gear assembly. Various types of fittings, connections, connectors and/or connector receptacles may be provided at one end of the rotatable shaft extending from the housing to releasably engage an IO device with the powered driver.
Examples of powered drivers are shown in pending patent application Ser. No. 10/449,503 filed May 30, 2003 entitled “Apparatus and Method to Provide Emergency Access To Bone Marrow,” Ser. No. 10/449,476 filed May 30, 2003 entitled “Apparatus and Method to Access Bone Marrow,” and Ser. No. 11/042,912 filed Jan. 25, 2005 entitled “Manual Intraosseous Device.”
Vascular system access may be essential for treatment of many serious diseases, chronic conditions and acute emergency situations. Yet, many patients experience extreme difficulty obtaining effective treatment because of inability to obtain or maintain intravenous (IV) access. An intraosseous (IO) space provides a direct conduit to a patent's vascular system and systemic circulation. Therefore, IO access is generally an effective route to administer a wide variety of drugs, other medications and fluids equivalent to IV access. Rapid IO access offers great promise for almost any serious emergency that requires vascular access to administer life saving drugs, other medications and/or fluids when traditional IV access is difficult or impossible.
Bone marrow typically includes blood, blood forming cells, and connective tissue disposed in an intraosseous space or cavity surrounded by compact bone. Long bones such as the tibia typically have an elongated central cavity filled with yellow bone marrow and adipose or connective tissue. Such cavities may also be referred to as a “medullary cavity”, “bone marrow cavity” and/or “intraosseous space.”
Compact bone disposed nearer the anterior or dorsal surface shall be referred to as “anterior compact bone” or “anterior bone cortex.” Compact bone disposed farther from the dorsal or anterior surface may be referred to as “posterior compact bone” or “posterior bone cortex.”
The upper tibia proximate a patient's knee or the humeral head proximate a patient's shoulder may be used as insertion sites for an IO device to establish access with the patient's vascular system. Sternal access may also be used as an insertion site. Availability of multiple intraosseous insertion sites and associated target areas in adjacent bone marrow have proven to be especially important in applications such as emergency treatment of battlefield casualties or other mass casualty situations. Teachings of the present disclosure may be used at a wide variety of insertion sites and target areas. Teachings of the present disclosure are not limited to power drivers and/or IO devices which may be inserted at the proximal tibia, distal tibia, humerus, or sternum.
IO access may be used as a “bridge” for temporary fluid and/or drug therapy during emergency conditions until conventional IV sites can be found and used. Conventional IV sites often become available because fluids and/or medication provided via IO access may stabilize a patient and expand veins and other portions of a patient's vascular system. IO devices and associated procedures incorporating teachings of the present disclosure may become standard care for administering medications and fluids in situations when IV access is difficult or not possible.
Intraosseous access may be used as a “routine” procedure with chronic conditions which substantially reduce or eliminate availability of conventional IV sites. Examples of such chronic conditions may include, but are not limited to, dialysis patients, patients in intensive care units and epilepsy patients. Intraosseous devices and associated apparatus incorporating teachings of the present disclosure may be quickly and safely used to provide IO access to a patient's vascular system in difficult cases such as status epilepticus to give medical personnel an opportunity to administer crucial medications and/or fluids. Further examples of such acute and chronic conditions are listed near the end of this written description.
In accordance with teachings of the present disclosure, apparatus and methods are provided for gaining rapid access to a patient's vascular system. One embodiment may include a powered driver operable to insert an intraosseous device into a patient's bone marrow at a selected target site. The powered driver may include a variable speed mechanism such as a low voltage potentiometer or any other electrical device satisfactory to allow varying the speed of an associated motor.
One embodiment of the present disclosure may provide an apparatus operable to insert an intraosseous device into a bone and associated bone marrow. The apparatus may include a housing, a drive shaft, a motor, a power supply and associated electrical circuit, and a light. The drive shaft may extend from an opening in the housing and may be operable to releasably engage the intraosseous device. The motor may be disposed within the housing and rotatably engaged with the drive shaft. The power supply and associated electrical circuit may be operable to power the motor. The light may extend from the housing and be connected to the power supply and the light may be operable to illuminate an insertion site for the intraosseous device.
Another embodiment of the present disclosure may provide a powered driver operable to insert an intraosseous device into a bone and associated bone marrow. The powered driver may include a housing, a drive shaft extending from the housing, a motor, a power supply, electrical circuits, and a switch connected to the electrical circuits. The drive shaft may be operable to releasably engage the intraosseous device. The motor may be disposed within the housing and rotatably engaged with the drive shaft. The power supply and associated electrical circuit may be operable to power the motor. The switch may be operable to activate the motor to rotate the drive shaft.
Another embodiment of the present disclosure may provide an apparatus operable to insert an intraosseous device into a bone and associated bone marrow and to assist with other medical procedures. The apparatus may include a powered driver, a drive shaft, a motor, a power supply and electrical circuits, a switch, and a suction pump. The powered driver may have a housing with one end of the drive shaft extending therefrom. The one end of the drive shaft may be operable to releasably engage the intraosseous device. The motor may be disposed within the housing and rotatably engaged with the drive shaft. The power supply and electrical circuits may be operable to power the motor. The switch may be operable to activate the motor to rotate the drill shaft. The suction pump may have a connector operable to be releasably engaged with the one end of the drive shaft whereby the powered driver may operate the pump.
A more complete and thorough understanding of the present embodiments and advantages thereof may be acquired by referring to the following description taken in conjunction with the accompanying drawings, in which like reference numbers indicate like features, and wherein:
Preferred embodiments of the disclosure and its advantages are best understood by reference to
Apparatus and methods incorporating teachings of the present disclosure may be used to provide intraosseous access to a patient's vascular system in the sternum, the proximal humerus (the shoulder area), the proximal tibia (below the knee) and the distal tibia (above the inside of the ankle). The distal tibia may provide easier vascular access to morbidly obese patients. The distal tibia is usually a thinner area of the body. Using the distal tibia as an insertion site may allow emergency medical service personnel to pump medications and fluids into the body of obese patients when regular conventional IV access is difficult. EMS personnel may often not be able to start IVs in obese patients because their size may obscure many of the veins used for conventional IV access. Adipose tissue (fat) around normal IO access sites may be so thick that EMS personnel can't reach adjacent the bone with standard IO needles. Therefore, the distal tibia may provide an IO access site for the overweight population.
One aspect of the present disclosure may include providing a powered driver and respective IO needle sets for safe and controlled vascular access to provide medication and fluids to bone marrow, to remove biopsies of bone and/or bone marrow and to aspirate bone marrow.
Apparatus and methods incorporating teachings of the present disclosure may be used with patients of all ages and weights. For example, one IO needle set may be appropriate for patients within the weight range of 3 kilograms to 39 kilograms. A second IO needle set may be satisfactory for use with patients weighing 40 kilograms or more.
For still other applications, teeth formed on one end of a cannula or catheter may be bent radially outward to reduce the amount of time and the amount of force required to penetrate bone and associated bone marrow using the cannula or catheter. For some applications a powered driver and aspiration needle set formed in accordance with teachings of the present disclosure may provide access to a patient's bone marrow using the same amount of torque. The length of time for penetrating a relatively hard bone may be increased as compared with the length of time required to penetrate a relatively softer bone.
The circuit may limit current supplied to the motor to protect associated batteries and to protect the motor for high current flow. High current flow may correspond with high torque which indicates improper use or operation of the powered driver. High torque may also indicate that the powered driver is not driving into bone. Current flow through the motor may be directly related to torque produced by the drive shaft. For some applications the circuit may indicate when current flow through the motor is typical for penetrating the hard outer layer of a bone (compact bone issue) with an IO device. The circuit may also indicate when current flow through the motor decreases in response to the IO device penetrating associated bone marrow.
For some embodiments the powered driver may include a trigger assembly operable to activate a low speed switch, a high speed switch and/or turn an associated motor off.
For some embodiments the powered driver may include a drive shaft having one end with a generally hexagonal cross section operable to be releasably engaged with intraosseous devices including, but not limited to, biopsy needles and bone marrow aspiration needles.
For some embodiments the powered driver may include a gear assembly rotatably attached to a motor. The gear assembly may have a speed reducing ratio between 60:1 and 80:1. For some applications the gear assembly may reduce speed of rotation of an attached motor at a ratio of approximately 66:1 or 77:1.
Apparatus and methods incorporating teachings of the present disclosure may include using a first IO needle set having a fifteen (15) gage cannula with a length of approximately fifteen (15) millimeters to establish vascular access for patients weighing between approximately three (3) kilograms and thirty nine (39) kilograms. A second IO needle set having a fifteen (15) gage cannula with an approximate length of twenty-five (25) millimeters may be used to establish vascular access for patients weighing forty (40) kilograms and greater.
For some applications intraosseous needles and needle sets incorporating teachings of the present disclosure may be formed from 304-stainless steel. Standard Luer lock catheter connections may be provided on each IO needle. IO needles and needle sets incorporating teachings of the present disclosure may be easily removed from an insertion site without the use of special tooling or equipment. The reduced size and weight of drivers and IO devices incorporating teachings of the present disclosure accommodate use in emergency crash carts and emergency medical vehicles.
The term “driver” as used in this application may include any type of powered driver satisfactory for inserting an intraosseous (IO) device including, but not limited to, a penetrator assembly, catheter, IO needle, IO needle set, biopsy needle or aspiration needle into a selected portion of a patient's vascular system. Various techniques may be satisfactorily used to releasably engage or attach an IO device with a driver incorporating teachings of the present disclosure. A wide variety of connectors and associated connector receptacles, fittings and/or other types of connections with various dimensions and configurations may be satisfactorily used to releasably engage an IO device with a driver. A battery powered driver incorporating teachings of the present disclosure may be used to insert an intraosseous device into a selected target area in ten seconds or less.
The term “intraosseous (IO) device” may be used in this application to include any hollow needle, hollow drive bit, penetrator assembly, bone penetrator, catheter, cannula, trocar, inner penetrator, outer penetrator, IO needle or IO needle set operable to provide access to an intraosseous space or interior portions of a bone.
For some applications an IO needle or IO needle set may include a connector with a trocar or stylet extending from a first end of the connector. A second end of the connector may be operable to be releasably engaged with a powered driver incorporating teachings of the present disclosure. An IO needle or IO needle set may also include a hub with a hollow cannula or catheter extending from a first end of the hub. A second end of the hub may include an opening sized to allow inserting the trocar through the opening and the hollow cannula. The second end of the hub may also be operable to be releasably engaged with the first end of the connector. As previously noted, the second end of the connector may be releasably engaged with a powered driver. A wide variety of connectors and hubs may be used with an IO device incorporating teaching of the present disclosure. The present disclosure is not limited to connector 180 or hub 200 as shown in
Various features of the present disclosure may be described with respect to powered drivers 30 and 30a-30f. Various features of the present disclosure may also be described with respect to intraosseous devices such as shown in
Powered driver 30 as shown in
Various components associated with powered driver 30 may be disposed within housing 32. For example a power source such as rechargeable battery pack 34 may be disposed within handle 36. Battery pack 34 may have various configurations and may include multiple batteries disposed within sealed packaging material. For other applications, a non-rechargeable battery pack may also be disposed within handle 36.
Handle 36 may be generally described as an elongated, hollow container sized to receive battery pack or power supply 34. Cap 38 may be disposed on one end of handle 36. Cap 38 may be removed to allow inserting and removing battery pack 34 therefrom. Handle 36 may also include finger grips 64 having generally ergonomic configurations.
For embodiments such as shown in
Motor 44 and gear assembly 46 may also be disposed within portions of housing 32 adjacent to handle 36. For embodiments represented by powered drivers 30-30e and 330a-330k, motor 44 and gear assembly 46 may be generally aligned with each other. Motor 44 may be connected with one end of gear assembly 46. Drive shaft 52 may be engaged with and extend from another end of gear assembly 46 opposite from motor 44.
For some applications both motor 44 and gear assembly 46 may have generally cylindrical configurations. Exterior portion 45 of motor 44 may correspond with the largest nominal outside diameter associated with motor 44. Exterior portion 47 of gear assembly 46 may correspond with the largest nominal outside diameter associated with gear assembly 46. For embodiments of the present disclosure represented by powered drivers 30-30e and 330a-330k, exterior portion 47 of gear assembly 46 may represent a nominal outside diameter portion larger than any other outside diameter portion associated with motor 44. In other embodiments of the present disclosure represented by powered driver 330i, exterior portion 47 of gear assembly 46 may be smaller than outside diameter portions associated with impact device 44a.
Portions of housing 32 may have generally similar cylindrical configurations corresponding with exterior portions of motor 44 and gear assembly 46. For example, segment 32a of housing 32 may have a generally cylindrical, hollow configuration with an inside diameter compatible with exterior portion 45 of motor 44. Housing segment 32b may have a generally cylindrical, hollow configuration with an inside diameter compatible with exterior portion 47 of gear assembly 46. Since portions of gear assembly 46 have an outside diameter that is larger than the outside diameter of motor 44, housing segment 32b may have a larger outside diameter than the outside diameter of housing segment 32a.
Motors and gear assemblies satisfactory for use with a powered driver incorporating teachings of the present disclosure may be obtained from various vendors. Such motor and gear assemblies are typically ordered as “sets” with one end of each motor securely attached to an adjacent end of an associated gear assembly. The gear assemblies may sometimes be referred to as “reduction gears” or “planetary gears”.
A drive shaft having desired dimensions and configuration may extend from the gear assembly opposite from the motor. The drive shaft may be provided as part of each motor and gear assembly set. The dimensions and/or configuration of an associated housing may be modified in accordance with teachings of the present disclosure to accommodate various types of motors, gear assemblies and/or drive shafts. For example, powered drivers used with aspiration needles and/or biopsy needles may include gear assemblies with larger dimensions required to accommodate larger speed reduction ratios, for example between 60:1 and 80:1, resulting in slower drive shaft RPM. Powered drivers used to provide intraosseous access during emergency medical procedures may operate at a higher speed and may include gear assemblies having a smaller speed reduction ratio, for example between 10:1 and 30:1, resulting in higher drive shaft RPM. For some applications, the difference in size for gear assemblies may result in increasing the inside diameter of an associated housing by approximately two to three millimeters to accommodate larger gear assemblies associated with powered drivers used to insert biopsy needles and/or aspiration needles.
Distal end or first end 48 of housing 32 may include opening 50 with portions of drive shaft 52 extending therefrom. For some applications the portion of drive shaft 52 extending from housing 32 may have a generally pentagonal shaped cross section with tapered surfaces 54 disposed thereon. Tapered surfaces 54 may be disposed at an angle of approximately three (3°) degrees with respect to a longitudinal axis or rotational axis (not expressly shown) associated with drive shaft 52. Relatively small magnet 56 disposed on the extreme end of drive shaft 52 opposite from housing 32. Fittings and/or connectors with various dimensions and/or configurations other than drive shaft 52 and/or magnet 56 may also be satisfactorily used with a powered driver incorporating teachings of the present disclosure.
Intraosseous devices having corresponding tapered openings or connector receptacles may be releasably engaged with portions of drive shaft 52 extending from housing 32. For example, portions of drive shaft 52 extending from distal end 48 may be releasably engaged with tapered opening 186 in connector 180 as shown in
For embodiments such as shown in
A block diagram showing one example of electrical circuits and other components which may be satisfactory used with a powered driver incorporating teachings of the present disclosure is shown in
A wide variety of electrical circuits and/or electronic indicators may be used with power supply status indicator 70. Additional information concerning such electrical circuits and displays may be described with respect to various power supply status indicators as shown in
A wide variety of charging circuits, voltage regulators and variable speed controllers may be satisfactorily used with a powered driver incorporating teachings of the present disclosure. Various examples of such charging circuits, voltage regulators and/or variable speed controllers are shown in
Switch 62 may be provided to prevent inadvertent or undesired activation of motor 44. Switch 62 may prevent discharge of battery 34 when an associated powered device is carried in a backpack and/or mobile storage container. An associated button 72a may be disposed on exterior portions of a housing to activate the variable speed controller 460. Button 72a may be located at various positions on the exterior of a housing associated with a powered driver incorporating teachings of the present disclosure as shown in
Materials used to form cradle 280 may be relatively low cost but durable. Such materials may be relatively stiff to secure a powered driver therein and may also flex without breaking to allow inserting and removing a powered driver at least five hundred (500) times.
Cradle 280 may have a length and width selected to be compatible with exterior portions of housing 32 and corresponding dimensions of powered driver 30. For some applications first end 281 and second end 282 may have generally rounded configurations. A notch (not expressly shown) may also be formed in first end 281 to accommodate portions of drive shaft 52. Various types of holders, clamps or quick release mechanisms may be included as part of cradle 280. For embodiments such as shown in
Arms 284 may be relatively strong with sufficient flexibility to allow inserting and removing portions of powered driver 30 from engagement with cradle 280. The height of arms 284 relative to adjacent longitudinal edges of cradle 280 may be based at least in part on the corresponding dimensions of handle 36 and other portions of housing 32. The spacing or gap formed between arms 284 may be selected to accommodate the width of handle 36. Respective rib 286 may be formed on the end of each arm 284. The configuration of ribs 286 may be selected to be compatible with a snug but releasable snap fit with adjacent portions of handle 36.
For some applications walls or partitions 290 may be formed adjacent to respective arms 294. Only one wall 290 is shown in
End 282 of cradle 280 may be modified to include electrical contact (not expressly shown) operable to engage recharging contacts 40a and 40b. Electric power cable 292 may also extend from end 282. Electrical power cable 292 may be inserted into an appropriate electrical outlet for use in recharging powered driver 30. A plurality of lights 296, 298 and 300 may be provided on exterior portions of cradle 300 to indicate the status of rechargeable battery 34. For example light 296 may indicate red when rechargeable battery 34 is discharged below a desired level. Light 298 may be flashing yellow to indicate that rechargeable battery 34 is being recharged and/or discharged. Light 300 may be steady green to indicate when rechargeable battery 34 has been fully recharged. Lights 296, 298 and 300 may also alternately blink or have a steady state condition.
Powered drive 30a as shown in
An embodiment of the present disclosure is shown in
A further embodiment of the present disclosure is shown in
Powered drivers 30d and 30e as shown in
A further embodiment of a rechargeable powered driver incorporating teachings of the present disclosure is shown in
Power sensor circuit 600c may detect current changes between impact device 44a and power supply 34. In some applications, current changes between impact device 44a and power supply 34 may indicate bone penetration is complete. Power sensor circuit 600c may be operable to automatically reduce or cut power from power supply 34 to impact device 44a once the associated intraosseous device has penetrated the cortex of the bone.
An intraosseous device (IO), sometimes referred to as a penetrator assembly or IO needle set, may include an outer penetrator such as a cannula, needle or hollow drive bit which may be of various sizes. Needles may be small (for pediatric patients), medium (for adults) and large (for over-sized adults). Penetrator, cannulas or needles may be provided in various configurations depending on the clinical purpose for needle insertion. For example, there may be one configuration for administering drugs and fluids and an alternate configuration for sampling bone marrow or for other diagnostic purposes although one needle configuration may be suitable for both purposes. Needle configuration may vary depending on the site chosen for insertion of a needle.
A wide variety of trocars, spindles and/or shafts may be disposed within a catheter or cannula during insertion at a selected insertion site. Such trocars, spindles and shafts may also be characterized as inner penetrators. A catheter, cannula, hollow needle or hollow drive bit may sometimes be characterized as an outer penetrator.
For some applications a layer or coating (not expressly shown) of an anticoagulant such as, but not limited to, heparin may be placed on interior and/or exterior portions of a catheter or cannula to prevent thrombotic occlusion of the catheter or cannula. Anticoagulants may reduce platelet adhesion to interior surfaces of the catheter or cannula and may reduce clotting time of blood flowing into and through the catheter or cannula. Placing a layer of an anticoagulant on exterior portions of a catheter or cannula adjacent to an associated tip and/or side ports may be helpful to prevent clotting.
Penetrator assembly 160 as shown in
Metallic disc 170 may be disposed within opening 186 for use in releasably attaching connector 180 with magnet 56 disposed on the end of drive shaft 52. End 223 of inner penetrator 220 is preferably spaced from metallic disc 170 with insulating or electrically nonconductive material disposed therebetween.
Tip 211 of outer penetrator 210 and/or tip 222 of inner penetrator 220 may be operable to penetrate bone and associated bone marrow. The configuration of tips 211 and/or 222 may be selected to penetrate a bone or other body cavities with minimal trauma. First end or tip 222 of inner penetrator 220 may be trapezoid shaped and may include one or more cutting surfaces. In one embodiment outer penetrator 210 and inner penetrator 220 may be ground together as one unit during an associated manufacturing process. Providing a matching fit allows respective tips 211 and 222 to act as a single driving unit which facilitates insertion and minimizes damage as portions of penetrator assembly 160 are inserted into a bone and associated bone marrow. Outer penetrator 210 and/or inner penetrator 220 may be formed from stainless steel, titanium or other materials of suitable strength and durability to penetrate bone.
Hub 200 may be used to stabilize penetrator assembly 160 during insertion of an associated penetrator into a patient's skin, soft tissue and adjacent bone at a selected insertion site. First end 201 of hub 200 may be operable for releasable engagement or attachment with associated connector 180. Second end 202 of hub 200 may have a size and configuration compatible with an associated insertion site for outer penetrator 210. The combination of hub 200 with outer penetrator 210 may sometimes be referred to as a “penetrator set” or intraosseous needle.
Connector 180 and attached inner penetrator 220 may be releasably engaged with each other by Luer type fittings, threaded connections or other suitable fittings formed on first end 201 of hub 200. Outer penetrator 210 extends from second end 202 of hub 200.
For some applications connector 180 may be described as a generally cylindrical tube defined in part by first end 181 and second end 182. The exterior of connector 180 may include an enlarged tapered portion adjacent to end 181. A plurality of longitudinal ridges 190 may be formed on the exterior of connector 180 to allow an operator to grasp associated penetrator assembly 160 during attachment with a drive shaft. See
Second end 182 of connector 180 may include opening 185 sized to receive first end 201 of hub 200 therein. Threads 188 may be formed in opening 185 adjacent to second end 182 of connector 180. Threaded fitting 188 may be used in releasably attaching connector 180 with threaded fitting 208 adjacent to first end 201 of hub 200.
First end 201 of hub 200 may include a threaded connector 208 or other suitable fittings formed on the exterior thereof. First end 201 may have a generally cylindrical pin type configuration compatible with releasably engaging second end or box end 182 of connector 180.
For some applications end 202 of hub 200 may have the general configuration of a flange. Angular slot or groove 204 sized to receive one end of protective cover or needle cap 234 may be formed in end 202. Slot or groove 204 may be used to releasable engage a needle cover (not expressly shown) with penetrator assembly 160.
For some applications a penetrator assembly may include only a single, hollow penetrator. For other applications a penetrator assembly may include an outer penetrator such as a cannula, hollow needle or hollow drive bit and an inner penetrator such as a stylet, trocar or other removable device disposed within the outer penetrator. Penetrator 210 is one example of a single, hollow penetrator.
The size of a penetrator may vary depending upon the intended application for the associated penetrator assembly. Penetrators may be relatively small for pediatric patients, medium size for adults and large for oversize adults. By way of example, a penetrator may range in length from five (5) mm to thirty (30) mm. The diameter of a penetrator may range from eighteen (18) gauge to ten (10) gauge. The length and diameter of the penetrator used in a particular application may depend on the size of a bone to which the apparatus may be applied. Penetrators may be provided in a wide variety of configurations depending upon intended clinical purposes for insertion of the associated penetrator. For example, there may be one configuration for administering drugs and/or fluids to a patient's bone marrow and an alternative configuration for sampling bone marrow and/or blood from a patient. Other configurations may be appropriate for bone and/or tissue biopsy.
For some applications connector 180 may be described as having a generally cylindrical configuration defined in part by first end 181 and second end 182. SEE
First end 181 of connector of 180 may include opening 186 sized to receive portions drive shaft 52 therein. A plurality of webs 136 may extend radially outward from connector receptacle 186. Webs 136 cooperate with each other to form a plurality of openings 138 adjacent to first end 181. Opening 186 and openings 138 cooperate with each other to form portions of a connector receptacle operable to receive respective portions of connector 30 therein.
A wide variety of accessory tools and devices are frequently carried by emergency medical service personnel and/or first responders. Pump assembly 130 as shown in
First end 154 of connector receptacle 152 may include opening 156 similar to opening 186 as described with respect to connector 180. End 252 extending from power driver 230a may be disposed within opening 156 to rotate connector receptacle 152 and attached components of pump assembly 130a. As a result, powered driver 230a may be used to pump fluids from inlet 131 through pump assembly 130a and outwardly from outlet 132.
Examples of acute and chronic conditions which may be treated using powered drivers, intraosseous devices, and procedures incorporating teachings of the present disclosure include, but are not limited to, the following:
Although the present disclosure and its advantages have been described in detail, it should be understood that various changes, substitutions and alternations can be made herein without departing from the spirit and scope of the disclosure as defined by the following claims.
This Application claims the benefit of U.S. Provisional Patent Application Ser. No. 60/910,122 entitled “Powered Drivers, Intraosseous Device and Methods to Access Bone Marrow” filed Apr. 4, 2007. This application is a continuation-in-part of U.S. patent application Ser. No. 10/449,476 entitled “Apparatus and Method to Access to Bone Marrow” filed May 30, 2003. This application is a continuation-in-part of U.S. patent application Ser. No. 11/253,467 entitled “Apparatus and Method to Access Bone Marrow” filed Oct. 19, 2005. This application is a continuation-in-part of U.S. patent application Ser. No. 11/253,959 entitled “Method and Apparatus to Access Bone Marrow” filed Oct. 19, 2005.
Number | Name | Date | Kind |
---|---|---|---|
1539637 | Bronner | May 1925 | A |
2317648 | Siqveland | Apr 1943 | A |
2419045 | Whittaker | Apr 1947 | A |
2773501 | Young | Dec 1956 | A |
3022596 | Cannon et al. | Feb 1962 | A |
3104448 | Morrow et al. | Sep 1963 | A |
3120845 | Horner | Feb 1964 | A |
3173417 | Horner | Mar 1965 | A |
3175554 | Stewart | Mar 1965 | A |
3507276 | Burgess et al. | Apr 1970 | A |
3543966 | Ryan et al. | Dec 1970 | A |
3734207 | Fishbein | May 1973 | A |
3815605 | Schmidt et al. | Jun 1974 | A |
3835860 | Garretson et al. | Sep 1974 | A |
3893445 | Hofsess | Jul 1975 | A |
3935909 | Mabuchi et al. | Feb 1976 | A |
3991765 | Cohen | Nov 1976 | A |
3999110 | Ramstrom et al. | Dec 1976 | A |
4021920 | Kirschner et al. | May 1977 | A |
4099518 | Baylis et al. | Jul 1978 | A |
4124026 | Berner et al. | Nov 1978 | A |
4142517 | Stavropoulos | Mar 1979 | A |
4170993 | Alvarez | Oct 1979 | A |
4185619 | Reiss | Jan 1980 | A |
4194505 | Schmitz | Mar 1980 | A |
4258722 | Sessions et al. | Mar 1981 | A |
4262676 | Jamshidi | Apr 1981 | A |
4306570 | Matthews | Dec 1981 | A |
4333459 | Becker | Jun 1982 | A |
4381777 | Garnier | May 1983 | A |
4441563 | Walton, II | Apr 1984 | A |
4469109 | Mehl | Sep 1984 | A |
4484577 | Sackner et al. | Nov 1984 | A |
4543966 | Islam et al. | Oct 1985 | A |
4553539 | Morris | Nov 1985 | A |
4605011 | Naslund | Aug 1986 | A |
4620539 | Andrews et al. | Nov 1986 | A |
4646731 | Brower | Mar 1987 | A |
4654492 | Koerner et al. | Mar 1987 | A |
4655226 | Lee | Apr 1987 | A |
4659329 | Annis | Apr 1987 | A |
4692073 | Martindell | Sep 1987 | A |
4711636 | Bierman | Dec 1987 | A |
4713061 | Tarello et al. | Dec 1987 | A |
4716901 | Jackson et al. | Jan 1988 | A |
4723945 | Theiling | Feb 1988 | A |
4758225 | Cox et al. | Jul 1988 | A |
4762118 | Lia et al. | Aug 1988 | A |
4772261 | Von Hoff et al. | Sep 1988 | A |
4787893 | Villette | Nov 1988 | A |
4793363 | Ausherman et al. | Dec 1988 | A |
4867158 | Sugg | Sep 1989 | A |
4919146 | Rhinehart et al. | Apr 1990 | A |
4921013 | Spalink et al. | May 1990 | A |
4935010 | Cox et al. | Jun 1990 | A |
4940459 | Noce | Jul 1990 | A |
4944677 | Alexandre | Jul 1990 | A |
4969870 | Kramer et al. | Nov 1990 | A |
4986279 | O'Neill | Jan 1991 | A |
5002546 | Romano | Mar 1991 | A |
5025797 | Baran | Jun 1991 | A |
5036860 | Leigh et al. | Aug 1991 | A |
5057085 | Kopans | Oct 1991 | A |
5074311 | Hasson | Dec 1991 | A |
5116324 | Brierley et al. | May 1992 | A |
5120312 | Wigness et al. | Jun 1992 | A |
5122114 | Miller et al. | Jun 1992 | A |
5133359 | Kedem | Jul 1992 | A |
5137518 | Mersch | Aug 1992 | A |
5139500 | Schwartz | Aug 1992 | A |
RE34056 | Lindgren et al. | Sep 1992 | E |
5172701 | Leigh et al. | Dec 1992 | A |
5172702 | Leigh et al. | Dec 1992 | A |
5176643 | Kramer et al. | Jan 1993 | A |
5195985 | Hall | Mar 1993 | A |
5203056 | Funk et al. | Apr 1993 | A |
5207697 | Carusillo | May 1993 | A |
5217478 | Rexroth | Jun 1993 | A |
5249583 | Mallaby | Oct 1993 | A |
5257632 | Turkel et al. | Nov 1993 | A |
5269785 | Bonutti | Dec 1993 | A |
5279306 | Mehl | Jan 1994 | A |
5312364 | Jacobs | May 1994 | A |
5324300 | Elias et al. | Jun 1994 | A |
5332398 | Miller et al. | Jul 1994 | A |
5333790 | Christopher | Aug 1994 | A |
5341823 | Manosalva et al. | Aug 1994 | A |
5348022 | Leigh et al. | Sep 1994 | A |
5357974 | Baldridge | Oct 1994 | A |
5361853 | Takamura et al. | Nov 1994 | A |
5368046 | Scarfone et al. | Nov 1994 | A |
5372583 | Roberts et al. | Dec 1994 | A |
5383859 | Sewell, Jr. | Jan 1995 | A |
5385553 | Hart et al. | Jan 1995 | A |
5400798 | Baran | Mar 1995 | A |
5405348 | Anspach et al. | Apr 1995 | A |
5423824 | Akerfeldt et al. | Jun 1995 | A |
5431655 | Melker et al. | Jul 1995 | A |
5451210 | Kramer et al. | Sep 1995 | A |
5484442 | Melker et al. | Jan 1996 | A |
D369858 | Baker et al. | May 1996 | S |
5526821 | Jamshidi | Jun 1996 | A |
5529580 | Kusunoki et al. | Jun 1996 | A |
5549565 | Ryan et al. | Aug 1996 | A |
5554154 | Rosenberg | Sep 1996 | A |
5556399 | Huebner et al. | Sep 1996 | A |
5558737 | Brown et al. | Sep 1996 | A |
5571133 | Yoon | Nov 1996 | A |
5586847 | Mattern, Jr. et al. | Dec 1996 | A |
5591188 | Waisman | Jan 1997 | A |
5595186 | Rubinstein et al. | Jan 1997 | A |
5601559 | Melker et al. | Feb 1997 | A |
5632747 | Scarborough et al. | May 1997 | A |
5651419 | Holzer et al. | Jul 1997 | A |
5713368 | Leigh | Feb 1998 | A |
5724873 | Hillinger | Mar 1998 | A |
5733262 | Paul | Mar 1998 | A |
5752923 | Terwilliger | May 1998 | A |
5762639 | Gibbs | Jun 1998 | A |
5766221 | Benderev et al. | Jun 1998 | A |
5769086 | Ritchart et al. | Jun 1998 | A |
5779708 | Wu | Jul 1998 | A |
5800389 | Burney et al. | Sep 1998 | A |
5801454 | Leininger | Sep 1998 | A |
5807277 | Swaim | Sep 1998 | A |
5809653 | Everts | Sep 1998 | A |
5810826 | Akerfeldt et al. | Sep 1998 | A |
5817052 | Johnson et al. | Oct 1998 | A |
5823970 | Terwilliger | Oct 1998 | A |
D403405 | Terwilliger | Dec 1998 | S |
5858005 | Kriesel | Jan 1999 | A |
5868711 | Kramer et al. | Feb 1999 | A |
5868750 | Schultz | Feb 1999 | A |
5873510 | Hirai et al. | Feb 1999 | A |
5885226 | Rubinstein et al. | Mar 1999 | A |
5891085 | Lilley et al. | Apr 1999 | A |
5911701 | Miller et al. | Jun 1999 | A |
5911708 | Teirstein | Jun 1999 | A |
5916229 | Evans | Jun 1999 | A |
5919172 | Golba, Jr. | Jul 1999 | A |
5924864 | Loge et al. | Jul 1999 | A |
5927976 | Wu | Jul 1999 | A |
5928238 | Scarborough et al. | Jul 1999 | A |
5928241 | Menut | Jul 1999 | A |
5941706 | Ura | Aug 1999 | A |
5941851 | Coffey et al. | Aug 1999 | A |
5960797 | Kramer et al. | Oct 1999 | A |
5980545 | Pacala et al. | Nov 1999 | A |
5984020 | Meyer et al. | Nov 1999 | A |
5993417 | Yerfino et al. | Nov 1999 | A |
5993454 | Longo | Nov 1999 | A |
6007496 | Brannon | Dec 1999 | A |
6017348 | Hart et al. | Jan 2000 | A |
6018094 | Fox | Jan 2000 | A |
6022324 | Skinner | Feb 2000 | A |
6027458 | Janssens | Feb 2000 | A |
6033369 | Goldenberg | Mar 2000 | A |
6033411 | Preissman | Mar 2000 | A |
6059806 | Hoegerle | May 2000 | A |
6063037 | Mittermeier et al. | May 2000 | A |
6071284 | Fox | Jun 2000 | A |
6080115 | Rubinstein | Jun 2000 | A |
6083176 | Terwilliger | Jul 2000 | A |
6086543 | Anderson et al. | Jul 2000 | A |
6086544 | Hibner et al. | Jul 2000 | A |
6092355 | Ishmael | Jul 2000 | A |
6096042 | Herbert | Aug 2000 | A |
6102915 | Bresler et al. | Aug 2000 | A |
6106484 | Terwilliger | Aug 2000 | A |
6110128 | Andelin et al. | Aug 2000 | A |
6110129 | Terwilliger | Aug 2000 | A |
6110174 | Nichter | Aug 2000 | A |
6120462 | Hibner et al. | Sep 2000 | A |
6126670 | Walker et al. | Oct 2000 | A |
6135769 | Kwan | Oct 2000 | A |
6159163 | Strauss et al. | Dec 2000 | A |
6162203 | Haaga | Dec 2000 | A |
6183442 | Athanasiou et al. | Feb 2001 | B1 |
6210376 | Grayson | Apr 2001 | B1 |
6217561 | Gibbs | Apr 2001 | B1 |
6221029 | Mathis et al. | Apr 2001 | B1 |
6228049 | Schroeder et al. | May 2001 | B1 |
6228088 | Miller et al. | May 2001 | B1 |
6238355 | Daum | May 2001 | B1 |
6247928 | Meller et al. | Jun 2001 | B1 |
6248110 | Reiley et al. | Jun 2001 | B1 |
6257351 | Ark et al. | Jul 2001 | B1 |
6273715 | Meller et al. | Aug 2001 | B1 |
6273862 | Privitera et al. | Aug 2001 | B1 |
6283925 | Terwilliger | Sep 2001 | B1 |
6283970 | Lubinus | Sep 2001 | B1 |
6287114 | Meller et al. | Sep 2001 | B1 |
6302852 | Fleming, III et al. | Oct 2001 | B1 |
6309358 | Okubo | Oct 2001 | B1 |
6312394 | Fleming, III | Nov 2001 | B1 |
6315737 | Skinner | Nov 2001 | B1 |
6325806 | Fox | Dec 2001 | B1 |
6328701 | Terwilliger | Dec 2001 | B1 |
6328744 | Harari et al. | Dec 2001 | B1 |
6358252 | Shapira | Mar 2002 | B1 |
6402701 | Kaplan et al. | Jun 2002 | B1 |
6419490 | Kitchings Weathers, Jr. | Jul 2002 | B1 |
6425888 | Embleton et al. | Jul 2002 | B1 |
6428487 | Burdorff et al. | Aug 2002 | B1 |
6443910 | Krueger et al. | Sep 2002 | B1 |
6468248 | Gibbs | Oct 2002 | B1 |
6478751 | Krueger et al. | Nov 2002 | B1 |
6488636 | Bryan et al. | Dec 2002 | B2 |
6523698 | Dennehey et al. | Feb 2003 | B1 |
6527736 | Attinger et al. | Mar 2003 | B1 |
6527778 | Athanasiou et al. | Mar 2003 | B2 |
6540694 | Van Bladel et al. | Apr 2003 | B1 |
6547511 | Adams | Apr 2003 | B1 |
6547561 | Meller et al. | Apr 2003 | B2 |
6554779 | Viola et al. | Apr 2003 | B2 |
6555212 | Boiocchi et al. | Apr 2003 | B2 |
6582399 | Smith et al. | Jun 2003 | B1 |
6585622 | Shum et al. | Jul 2003 | B1 |
6595911 | LoVuolo | Jul 2003 | B2 |
6595979 | Epstein et al. | Jul 2003 | B1 |
6613054 | Scribner et al. | Sep 2003 | B2 |
6616632 | Sharp et al. | Sep 2003 | B2 |
6620111 | Stehens et al. | Sep 2003 | B2 |
6626848 | Neuenfeldt | Sep 2003 | B2 |
6626887 | Wu | Sep 2003 | B1 |
6638235 | Miller et al. | Oct 2003 | B2 |
6656133 | Voegele et al. | Dec 2003 | B2 |
6689072 | Kaplan et al. | Feb 2004 | B2 |
6702760 | Krause et al. | Mar 2004 | B2 |
6702761 | Damadian et al. | Mar 2004 | B1 |
6706016 | Cory et al. | Mar 2004 | B2 |
6716192 | Orosz, Jr. | Apr 2004 | B1 |
6716215 | David et al. | Apr 2004 | B1 |
6716216 | Boucher et al. | Apr 2004 | B1 |
6730043 | Krueger et al. | May 2004 | B2 |
6730044 | Stephens et al. | May 2004 | B2 |
6749576 | Bauer | Jun 2004 | B2 |
6752768 | Burdorff et al. | Jun 2004 | B2 |
6752816 | Culp et al. | Jun 2004 | B2 |
6758824 | Miller et al. | Jul 2004 | B1 |
6761726 | Findlay et al. | Jul 2004 | B1 |
6796957 | Carpenter et al. | Sep 2004 | B2 |
6846314 | Shapira | Jan 2005 | B2 |
6849051 | Sramek et al. | Feb 2005 | B2 |
6855148 | Foley et al. | Feb 2005 | B2 |
6860860 | Viola | Mar 2005 | B2 |
6875183 | Cervi | Apr 2005 | B2 |
6875219 | Arramon et al. | Apr 2005 | B2 |
6884245 | Spranza | Apr 2005 | B2 |
6887209 | Kadziauskas et al. | May 2005 | B2 |
6890308 | Islam | May 2005 | B2 |
6905486 | Gibbs | Jun 2005 | B2 |
6930461 | Rutkowski | Aug 2005 | B2 |
6942669 | Kurc | Sep 2005 | B2 |
6969373 | Schwartz et al. | Nov 2005 | B2 |
7008381 | Janssens | Mar 2006 | B2 |
7008383 | Damadian et al. | Mar 2006 | B1 |
7008394 | Geise et al. | Mar 2006 | B2 |
7025732 | Thompson et al. | Apr 2006 | B2 |
7063672 | Schramm | Jun 2006 | B2 |
7137985 | Jahng | Nov 2006 | B2 |
7207949 | Miles et al. | Apr 2007 | B2 |
7226450 | Athanasiou et al. | Jun 2007 | B2 |
7229401 | Kindlein | Jun 2007 | B2 |
7565935 | Phillips | Jul 2009 | B1 |
20010005778 | Ouchi | Jun 2001 | A1 |
20010014439 | Meller et al. | Aug 2001 | A1 |
20010047183 | Privitera et al. | Nov 2001 | A1 |
20010053888 | Athanasiou et al. | Dec 2001 | A1 |
20020042581 | Cervi | Apr 2002 | A1 |
20020050364 | Suzuki et al. | May 2002 | A1 |
20020055713 | Gibbs | May 2002 | A1 |
20020120212 | Ritchart et al. | Aug 2002 | A1 |
20020138021 | Pflueger | Sep 2002 | A1 |
20020158102 | Patton et al. | Oct 2002 | A1 |
20030028146 | Aves | Feb 2003 | A1 |
20030032939 | Gibbs | Feb 2003 | A1 |
20030036747 | Ie et al. | Feb 2003 | A1 |
20030050574 | Krueger | Mar 2003 | A1 |
20030114858 | Athanasiou et al. | Jun 2003 | A1 |
20030125639 | Fisher et al. | Jul 2003 | A1 |
20030153842 | Lamoureux et al. | Aug 2003 | A1 |
20030191414 | Reiley et al. | Oct 2003 | A1 |
20030195436 | Van Bladel et al. | Oct 2003 | A1 |
20030195524 | Barner | Oct 2003 | A1 |
20030199787 | Schwindt | Oct 2003 | A1 |
20030216667 | Viola | Nov 2003 | A1 |
20030225344 | Miller | Dec 2003 | A1 |
20030225364 | Kraft et al. | Dec 2003 | A1 |
20030225411 | Miller | Dec 2003 | A1 |
20040019297 | Angel | Jan 2004 | A1 |
20040019299 | Ritchart et al. | Jan 2004 | A1 |
20040034280 | Privitera et al. | Feb 2004 | A1 |
20040049128 | Miller et al. | Mar 2004 | A1 |
20040064136 | Papineau et al. | Apr 2004 | A1 |
20040073139 | Hirsch et al. | Apr 2004 | A1 |
20040092946 | Bagga et al. | May 2004 | A1 |
20040153003 | Cicenas et al. | Aug 2004 | A1 |
20040158172 | Hancock | Aug 2004 | A1 |
20040158173 | Voegele et al. | Aug 2004 | A1 |
20040162505 | Kaplan et al. | Aug 2004 | A1 |
20040191897 | Muschler | Sep 2004 | A1 |
20040210161 | Burdorff et al. | Oct 2004 | A1 |
20040215102 | Ikehara et al. | Oct 2004 | A1 |
20040220497 | Findlay et al. | Nov 2004 | A1 |
20050027210 | Miller | Feb 2005 | A1 |
20050040060 | Andersen et al. | Feb 2005 | A1 |
20050075581 | Schwindt | Apr 2005 | A1 |
20050085838 | Thompson et al. | Apr 2005 | A1 |
20050101880 | Cicenas et al. | May 2005 | A1 |
20050113716 | Mueller, Jr. et al. | May 2005 | A1 |
20050116673 | Carl | Jun 2005 | A1 |
20050124915 | Eggers et al. | Jun 2005 | A1 |
20050131345 | Miller | Jun 2005 | A1 |
20050148940 | Miller | Jul 2005 | A1 |
20050165328 | Heske et al. | Jul 2005 | A1 |
20050165403 | Miller | Jul 2005 | A1 |
20050165404 | Miller | Jul 2005 | A1 |
20050171504 | Miller | Aug 2005 | A1 |
20050182394 | Spero et al. | Aug 2005 | A1 |
20050200087 | Vasudeva et al. | Sep 2005 | A1 |
20050203439 | Heske et al. | Sep 2005 | A1 |
20050209530 | Pflueger | Sep 2005 | A1 |
20050215921 | Hibner et al. | Sep 2005 | A1 |
20050228309 | Fisher et al. | Oct 2005 | A1 |
20050261693 | Miller et al. | Nov 2005 | A1 |
20060011506 | Riley | Jan 2006 | A1 |
20060015066 | Turieo et al. | Jan 2006 | A1 |
20060036212 | Miller | Feb 2006 | A1 |
20060052790 | Miller | Mar 2006 | A1 |
20060074345 | Hibner | Apr 2006 | A1 |
20060079774 | Anderson | Apr 2006 | A1 |
20060089565 | Schramm | Apr 2006 | A1 |
20060122535 | Daum | Jun 2006 | A1 |
20060129082 | Rozga | Jun 2006 | A1 |
20060144548 | Beckman et al. | Jul 2006 | A1 |
20060149163 | Hibner et al. | Jul 2006 | A1 |
20060151188 | Bodine et al. | Jul 2006 | A1 |
20060167377 | Ritchart et al. | Jul 2006 | A1 |
20060167378 | Miller | Jul 2006 | A1 |
20060167379 | Miller | Jul 2006 | A1 |
20060184063 | Miller | Aug 2006 | A1 |
20060189940 | Kirsch | Aug 2006 | A1 |
20070016100 | Miller | Jan 2007 | A1 |
20070049945 | Miller | Mar 2007 | A1 |
20070149920 | Michels et al. | Jun 2007 | A1 |
20070213735 | Sandat et al. | Sep 2007 | A1 |
20070270775 | Miller et al. | Nov 2007 | A1 |
20080015467 | Miller | Jan 2008 | A1 |
20080015468 | Miller | Jan 2008 | A1 |
20080045857 | Miller | Feb 2008 | A1 |
20080045860 | Miller et al. | Feb 2008 | A1 |
20080045861 | Miller et al. | Feb 2008 | A1 |
20080045965 | Miller et al. | Feb 2008 | A1 |
20080087448 | Happ | Apr 2008 | A1 |
20080140014 | Miller et al. | Jun 2008 | A1 |
20080215056 | Miller et al. | Sep 2008 | A1 |
20080221580 | Miller et al. | Sep 2008 | A1 |
Number | Date | Country |
---|---|---|
2138842 | Jun 1996 | CA |
2 454 600 | Jan 2004 | CA |
10057931 | Nov 2000 | DE |
517000 | Dec 1992 | EP |
0807412 | Nov 1997 | EP |
1099450 | May 2001 | EP |
1314452 | May 2003 | EP |
853349 | Mar 1940 | FR |
2457105 | May 1979 | FR |
2516386 | Nov 1981 | FR |
2130890 | Jun 1984 | GB |
1052433 | Feb 1989 | JP |
9307819 | Apr 1993 | WO |
9631164 | Oct 1996 | WO |
9806337 | Feb 1998 | WO |
9918866 | Apr 1999 | WO |
9952444 | Oct 1999 | WO |
0056220 | Sep 2000 | WO |
0178590 | Oct 2001 | WO |
0241792 | May 2002 | WO |
0241792 | May 2002 | WO |
02096497 | Dec 2002 | WO |
2005110259 | Nov 2005 | WO |
2005112800 | Dec 2005 | WO |
2008081438 | Jul 2008 | WO |
Entry |
---|
International PCT Search Report PCT/US03/17167, 8 pages, Mailed Sep. 16, 2003. |
International PCT Search Report PCT/US03/17203, 8 pages, Mailed Sep. 16, 2003. |
International PCT Search Report PCT/US2004/037753, 6 pages, Mailed Apr. 19, 2005. |
Communication relating to the results of the partial International Search Report for PCT/US2005/002484, 6 pages, Mailed May 19, 2005. |
International PCT Search Report and Written Opinion PCT/US2004/037753, 16 pages, Mailed Jul. 8, 2005. |
International PCT Search Report and Written Opinion PCT/US2005/002484, 15 pages, Mailed Jul. 22, 2005. |
Cummins, Richard O., et al, “ACLS-Principles and Practice”, ACLS—The Reference Textbook, American Heart Association, pp. 214-218, 2003. |
Riley et al., “A Pathologist's Perspective on Bone Marrow Aspiration Biopsy: I. Performing a Bone Marrow Examination,” Journal of Clinical Laboratory Analysis 18, pp. 70-90, 2004. |
International Preliminary Report on Patentability PCT/US2005/002484, 9 pages, Mailed Aug. 3, 2006. |
Official Action for European Application No. 03756317.8 (4 pages), Dec. 28, 2006. |
International Search Report and Written Opinion for International Application No. PCT/US2006/025201 (18 pages), Jan. 29, 2007. |
Pediatrics, Official Journal of the American Academy of Pediatrics, Pediatrics, 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care of Pediatric and Neonatal Patients:Pediatric Advanced Life Support, Downloaded from www.pediatrics.org, Feb. 21, 2007. |
Liakat A. Parapia, Trepanning or trephines: a history of bone marrow biopsy, British Journal of Haematology, pp. 14-19 2007, Date 2007. |
Australian Exam Report on Patent Application No. 2003240970, 2 pages, Oct. 15, 2007. |
Pediatric Emergency, Intraosseous Infusion for Administration of Fluids and Drugs, www.cookgroup.com, 1 pg, 2000. |
Michael Trotty, “Technology (A Special Report)—The Wall Street Journal 2008 Technology Innovation Awards—This years winners include: an IV alternative, a better way to make solar panels, a cheap, fuel efficient car and a better way to see in the dark”, The Wall Street Journal, Factiva, 5 pages, 2008. |
Buckley et al., CT-guided bone biopsy: Initial experience with commercially available hand held Black and Decker drill, European Journal of Radiology 61, pp. 176-180, 2007. |
Hakan et al., CT-guided Bone BiopsyPerformed by Means of Coaxial Bopsy System with an Eccentric Drill, Radiology, pp. 549-552, Aug. 1993. |
European Search Report 08158699.2-1265, 4 pages, Aug. 2008. |
International Search Report and Written Opinion, PCT/US2007/078204, 14 pages, Mailing Date May 15, 2008. |
International Search Report and Written Opinion, PCT/US08/52943, 8 pages, Mailing Date Sep. 26, 2008. |
European Office Action Communication, Application No. 08158699.2-1265/1967142, 10 pages, Nov. 4, 2008. |
Gunal et al., Compartment Syndrome After Intraosseous Infusion: An Expiremental Study in Dogs, Journal of Pediatric Surgery, vol. 31, No. 11, pp. 1491-1493, Nov. 1996. |
International Search Report, PCT/US2007/072217, 20 pages, Mailing Date Mar. 31, 2008. |
International Search Report, PCT/US2007/072209, 18 pages, Mailing Date Apr. 25, 2008. |
International Search Report, PCT/US2006/025201, 12 pages, Mailing Date Feb. 7, 2008. |
Communication Pursuant to Article 94(3) EPC, Application No. 05 712 091.7-1265, 4 pages, Apr. 8, 2008. |
Notification of the First Chinese Office Action, Application No. 200580003261.8, 3 pages, Mar. 21, 2008. |
International Search Report and Written Opinion, PCT/US08/500346, 12 pages, Mailing Date May 22, 2008. |
PCT Invitation to Pay Additional Fees, PCT/US2007/072209, 9 pages, Mailing Dec. 3, 2007. |
“Proven reliability for quality bone marrow samples”, Special Procedures, Cardinal Health, 6 pages, 2003. |
F.A.S.T. 1 Intraosseous Infusion System with Depth-Control Mechanism Brochure, 6 pages, 2000. |
BioAccess.com, Single Use Small Bone Power Tool—How It Works, 1 pg, Printed Jun. 9, 2008. |
International Search Report and Written Opinion, PCT/US2007/078203, 15 pages, Mailing Date May 13, 2008. |
International Search Report and Written Opinion, PCT/US2007/072202, 17 pages, Mailing Date Mar. 25, 2008. |
International Search Report and Written Opinion, PCT/US2007/078207, 13 pages, Mailing Date Apr. 7, 2008. |
International Search Report and Written Opinion, PCT/US2007/078205, 13 pages, Mailing date Sep. 11, 2007. |
European Office Action EP03731475.4, 4 pages, Oct. 11, 2007. |
U.S. Appl. No. 11/427,501 Non Final Office Action, 14 pages, Mailed Aug. 7, 2008. |
Chinese Office Action, Application No. 2005800003261, (with English translation), (9 pgs), Jan. 16, 2009. |
International Preliminary Report on Patentability, PCT/US/2007/078203, 13 pages, Mar. 26, 2009. |
International Preliminary Report on Patentability, PCT/US/2007/078207, 10 pages, Mar. 26, 2009. |
International Preliminary Report on Patentability, PCT/US/2007/078205, 10 pages, Mar. 26, 2009. |
International Preliminary Report on Patentability, PCT/US/2007/078204, 11 pages, Apr. 2, 2009. |
Vidacare Corporation Comments to Intraosseous Vascular Access Position Paper, Infusion Nurses Society, 6 pages, May 4, 2009. |
International Preliminary Report on Patentability, PCT/US/2007/072209, 10 pages, May 14, 2009. |
Japanese Office Action, Application No. 2004-508,670, (with English summary), (13 pgs), Apr. 21, 2009. |
PCT Preliminary Report on Patentability, PCT/US/2008/050346, (8 pgs), Jul. 23, 2009. |
Japanese Office Action, Application No. 2004-508,669, (with English summary), (9 pgs), Aug. 3, 2009. |
Chinese Office Action, Application No. 200780000590.6, (with English translation), (13 pgs), Aug. 21, 2009. |
European Office Action and Search Report, Application No. 09150973.7, (8 pgs), Oct. 23, 2009. |
Chinese Office Action with English translation; Application No. 200910006631.3; pp. 12, Mar. 11, 2010. |
European Extended Search Report, Application No. EP10153350.3, 5 pages, Mar. 11, 2010. |
European Extended Search Report, Application No. EP08021732.6, 7 pages, Nov. 13, 2009. |
European Office Action; Application No. 09 155 111.9-2310; pp. 3, Nov. 25, 2009. |
Chinese Office Action with English translation; Application No. 200910006631.3; pp. 13, Mar. 11, 2010. |
Taiwan Office Action , Application No. 94102179 (with English translation); 12 pages, May 13, 2010. |
Chinese Office Action with English translation; Application No. 200780001198.3; pp. 13, Apr. 27, 2010. |
Office Action issued in Chinese Application No. 200910006631.3, dated Mar. 22, 2011. |
Non-Final Office Action, U.S. Appl. No. 10/449,476, 8 pages, Oct. 29, 2008. |
Åström, K.G., “Automatic Biopsy Instruments Used Through a Coaxial Bone Biopsy System with an Eccentric Drill Tip,” Acta Radiologica, 1995; 36:237-242, May 1995. |
Åström, K. Gunnar O., “CT-guided Transsternal Core Biopsy of Anterior Mediastinal Masses,” Radiology 1996; 199:564-567, May 1996. |
International Preliminary Report on Patentability, PCT/US2007/072202, 10 pages, Mailed Jan. 15, 2009. |
International Preliminary Report on Patentability, PCT/US2007/072217, 11 pages, Mailed Feb. 12, 2009. |
State Intellectual Property Office of the People's Republic of China, First Office Action issued for Chinese Patent Application No. 200880000182.5, dated Sep. 10, 2010. |
State Intellectual Property Office of the People's Republic of China, Second Office Action issued for Chinese Patent Application No. 200880000182.5, dated Mar. 12, 2012. |
State Intellectual Property Office of the People'S Republic of China, Third Office Action issued for Chinese Patent Application No. 200880000182.5, dated Mar. Dec. 13, 2012. |
State Intellectual Property Office of the People'S Republic of China, Rejection Decision issued for Chinese Patent Application No. 200880000182.5, dated Jun. 27, 2013. |
State Intellectual Property Office of the People'S Republic of China, Reexamination Decision Issued for Chinese Patent Application No. 200880000182.5, dated Nov. 20, 2013. |
European Patent Office, Communication from Examining Division for European Patent Application No. 08799753.2, dated May 18, 2015. |
European Patent Office, Communication from Examining Division for European Patent Application No. 08799753.2, dated Sep. 29, 2014. |
European Patent Office, Communication from Examining Division for European Patent Application No. 08799753.2, dated Apr. 10, 2014. |
European Patent Office, European Search Report for European Patent Application No. 08799753.2, dated May 23, 2013. |
Number | Date | Country | |
---|---|---|---|
20080215056 A1 | Sep 2008 | US |
Number | Date | Country | |
---|---|---|---|
60910122 | Apr 2007 | US | |
60384756 | May 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11253959 | Oct 2005 | US |
Child | 12061944 | US | |
Parent | 11253467 | Oct 2005 | US |
Child | 11253959 | US | |
Parent | 10449476 | May 2003 | US |
Child | 11253467 | US |